Firm record
Alembic Pharmaceuticals Limited
▲Listed·India·GICS Pharmaceuticals, Biotechnology and Life Sciences·LEI 335800PM173KNG818V30
Partial profile
We haven't fully researched Alembic Pharmaceuticals Limited yet.
Request a full evidence-chained profile — we'll dig into their carbon, nature, social & water disclosure, find their facilities and sources, and email you when it's ready.
We’ll only use your email to notify you about this request.
Targets & commitments5
| Source | Type | Scope | Base | Target year | Value | Status |
|---|---|---|---|---|---|---|
| sbti | net_zero | Scope 1 + 2 + 3 | 2022 | 2050 | — | 1.5°C |
| sbti | — | — | — | — | — | — |
| sbti | long_term | Scope 1 + 2 + 3 | 2022 | 2050 | 90% | 1.5°C |
| sbti | — | — | — | — | — | — |
| sbti | near_term | Scope 1 + 2 + 3 | 2022 | 2034 | 63% | 1.5°C |
Identifiers
| lei | 335800PM173KNG818V30 |
| isin | INE901L01018 |
| sbti_id | 40004146 |
| ticker | APLLTD.NS |
| Reverberate ID | c4ed164c… |